Initial Therapeutics Revenue and Competitors

Location

#3266

Growjo Ranking

Biotech

Industry

Estimated Revenue & Valuation

  • Initial Therapeutics's estimated annual revenue is currently $2.2M per year.(i)
  • Initial Therapeutics's estimated revenue per employee is $77,500

Employee Data

  • Initial Therapeutics has 28 Employees.(i)
  • Initial Therapeutics grew their employee count by 75% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$4.4M57-8%$53MN/A
#2
$21.2M137-26%$110MN/A
#3
$0.9M60%N/AN/A
#4
$2.3M1515%N/AN/A
#5
$1.6M10-17%N/AN/A
#6
$0.7M950%N/AN/A
#7
$11.5M74-12%N/AN/A
#8
$0.4M27510%$236.7MN/A
#9
$4M51-74%$160MN/A
#10
$2.3M1515%N/AN/A
Add Company

What Is Initial Therapeutics?

Initial Therapeutics is discovering and developing a new class of small-molecule medicines designed to halt pathogenic protein formation in the earliest stages.Initial’s approach is unique and starkly differentiated from protein degradation and other interventions that recognize and tackle proteins only after they have been fully formed.

keywords:N/A

N/A

Total Funding

28

Number of Employees

$2.2M

Revenue (est)

75%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$2.9M28-24%$67.1M
#2
$2M2822%$2M
#3
$2M288%$247.3M
#4
$6M288%N/A
#5
$2.8M28N/AN/A